Interest Expense of VBI Vaccines Inc/BC from 31 Dec 2015 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
VBI Vaccines Inc/BC quarterly and annual Interest Expense in USD history and change rate from 31 Dec 2015 to 31 Mar 2024.
  • VBI Vaccines Inc/BC Interest Expense for the quarter ending 31 Mar 2024 was $1,818,000, a 27% increase year-over-year.
  • VBI Vaccines Inc/BC Interest Expense for the twelve months ending 31 Mar 2024 was $6,790,000, a 51% increase year-over-year.
  • VBI Vaccines Inc/BC annual Interest Expense for 2023 was $6,401,000, a 60% increase from 2022.
  • VBI Vaccines Inc/BC annual Interest Expense for 2022 was $4,007,000, a 15% decline from 2021.
  • VBI Vaccines Inc/BC annual Interest Expense for 2021 was $4,732,000, a 75% increase from 2020.
Source SEC data
View on sec.gov
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

VBI Vaccines Inc/BC Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $6,790,000 $1,818,000 +$389,000 +27% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $6,401,000 $1,721,000 +$513,000 +42% 01 Oct 2023 31 Dec 2023 10-K 16 Apr 2024 2023 FY
Q3 2023 $5,888,000 $1,543,000 +$585,000 +61% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $5,303,000 $1,708,000 +$807,000 +90% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $4,496,000 $1,429,000 +$489,000 +52% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 $4,007,000 $1,208,000 +$159,000 +15% 01 Oct 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 $3,848,000 $958,000 -$68,000 -6.6% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $3,916,000 $901,000 +$56,000 +6.6% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $3,860,000 $940,000 -$872,000 -48% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $4,732,000 $1,049,000 +$347,000 +49% 01 Oct 2021 31 Dec 2021 10-K 13 Mar 2023 2022 FY
Q3 2021 $4,385,000 $1,026,000 +$284,000 +38% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $4,101,000 $845,000 +$163,000 +24% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 $3,938,000 $1,812,000 +$1,230,000 +211% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $2,708,000 $702,000 +$178,000 +34% 01 Oct 2020 31 Dec 2020 10-K 07 Mar 2022 2021 FY
Q3 2020 $2,530,000 $742,000 +$116,000 +19% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021 2021 Q3
Q2 2020 $2,414,000 $682,000 +$116,000 +20% 01 Apr 2020 30 Jun 2020 10-Q 02 Aug 2021 2021 Q2
Q1 2020 $2,298,000 $582,000 +$102,000 +21% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q4 2019 $2,196,000 $524,000 -$137,000 -21% 01 Oct 2019 31 Dec 2019 10-K 02 Mar 2021 2020 FY
Q3 2019 $2,333,000 $626,000 -$90,000 -13% 01 Jul 2019 30 Sep 2019 10-Q 02 Nov 2020 2020 Q3
Q2 2019 $2,423,000 $566,000 -$150,000 -21% 01 Apr 2019 30 Jun 2019 10-Q 31 Jul 2020 2020 Q2
Q1 2019 $2,573,000 $480,000 -$59,000 -11% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q4 2018 $2,632,000 $661,000 -$32,000 -4.6% 01 Oct 2018 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q3 2018 $2,664,000 $716,000 -$26,000 -3.5% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2019 Q3
Q2 2018 $2,690,000 $716,000 -$27,000 -3.6% 01 Apr 2018 30 Jun 2018 10-Q 06 Nov 2019 2019 Q3
Q1 2018 $2,717,000 $539,000 -$165,000 -23% 01 Jan 2018 31 Mar 2018 10-Q 01 May 2019 2019 Q1
Q4 2017 $2,882,000 $693,000 +$335,000 +94% 01 Oct 2017 31 Dec 2017 10-K 25 Feb 2019 2018 FY
Q3 2017 $2,547,000 $742,000 +$804,000 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018 2018 Q3
Q2 2017 $1,743,000 $743,000 +$740,000 +24667% 01 Apr 2017 30 Jun 2017 10-Q 26 Jul 2018 2018 Q2
Q1 2017 $1,003,000 $704,000 +$679,000 +2716% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 $324,000 $358,000 01 Oct 2016 31 Dec 2016 10-K 20 Mar 2017 2016 FY
Q3 2016 $62,000 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017 2017 Q3
Q2 2016 $3,000 01 Apr 2016 30 Jun 2016 10-Q 31 Jul 2017 2017 Q2
Q1 2016 $25,000 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1

VBI Vaccines Inc/BC Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $6,401,000 +$2,394,000 +60% 01 Jan 2023 31 Dec 2023 10-K 16 Apr 2024 2023 FY
2022 $4,007,000 -$725,000 -15% 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY
2021 $4,732,000 +$2,024,000 +75% 01 Jan 2021 31 Dec 2021 10-K 13 Mar 2023 2022 FY
2020 $2,708,000 +$512,000 +23% 01 Jan 2020 31 Dec 2020 10-K 07 Mar 2022 2021 FY
2019 $2,196,000 -$436,000 -17% 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2021 2020 FY
2018 $2,632,000 -$250,000 -8.7% 01 Jan 2018 31 Dec 2018 10-K 05 Mar 2020 2019 FY
2017 $2,882,000 +$2,558,000 +790% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2019 2018 FY
2016 $324,000 -$781,000 -71% 01 Jan 2016 31 Dec 2016 10-K 20 Mar 2017 2016 FY
2015 $1,105,000 01 Jan 2015 31 Dec 2015 10-K 20 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.